Breast Biopsy Device Market Will Grow As Of Increasing Level Of Awareness For Breast Cancer

Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market.

Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.What the Market Looks Like?The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805Market Segmentation:-Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products.

In 2019, the biopsy needles held significant share of the market.

The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy.

The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy.

Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy.

According to the new market research report Breast Cancer Liquid Biopsy Market is expected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%.

The breast cancer liquid biopsy market is a consolidated market with a large number of companies offering breast cancer liquid biopsy instruments and accessories.

In 2016, QIAGEN N.V. (Netherlands), Roche Diagnostics (US), and Illumina, Inc. (US) dominated the breast cancer liquid biopsy market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150106081QIAGEN was the leading player in the breast cancer liquid biopsy market in 2017.

The company is a global provider of sample-to-insight solutions that aids in the transformation of biological samples into molecular insights.

The company operates through its two business segments, namely, instruments and consumables & related products.QIAGEN provides solutions to more than 500,000 customers globally, in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing, and food safety), pharma (pharma and biotech companies), and academia (life sciences research).

The company operates in the breast cancer liquid biopsy market through its molecular diagnostics and life science tools customer base segment.Roche Diagnostics ranked second in the breast cancer liquid biopsy market in 2017.

Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P Market ResearchOn the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy.

Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now.

It is also expected to be the fastest growing category during the forecast period.

This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sampleOn the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products.

Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share.

For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago.

Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023Increased cancer detection rates globally have contributed to a rise in biopsy procedures.

The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288  A biopsy is a small operation performed to remove tissue from the area of concern within the body.

There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.

In addition, market limitations include the high cost of surgical procedures and the complications involved.

Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.

Surgical biopsy is divided into incisional biopsy and excisional biopsy.Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.

Breast Biopsy Market – OverviewThe breast cancer market is expected to witness tremendous growth owing to the rising prevalence of breast cancer.

Other key factors such as the growing obesity among women, menstrual history, change in sedentary lifestyle, not having children, socioeconomic factors, and growing consumption of unhealthy diet are contributing towards the growth of the market.

Research suggests that other factors such as smoking, exposure to chemicals that can lead to cancer, and working in night shift also may increase the risk of breast cancer.

Furthermore, the rise in the awareness regarding cancer is anticipated to further motivate the expansion of the breast biopsy market in the forecast period.Competitive Analysis:Leading players in the global Biopsy Breast Market Procedure include Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE.

In September 2019, Candelis Inc. launched a new Advanced Breast Imaging Workstation as an enhancement to its ImageGrid platform.

Breast biopsy is further segmented into image-guided breast biopsy, tactic core biopsy, ultrasound-guided core biopsy, and others.On the basis of application, the global breast imaging market is segmented into breast cancer diagnosis, post-neoadjuvant chemotherapy, metastatic axillary adenocarcinoma, and others.On the basis of end user, the market is segmented into hospitals, diagnostic centers, and others.Regional Analysis:The Americas is the largest regional market for breast imaging.

We specialize in performing breast surgery, breast biopsy and breast augmentation procedures in Texas.

This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement.

The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6288The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market.

In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them.

At the same time, the emergence of technologically advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds.Market SegmentationThe global breast biopsy market segmentation is done as per technique type, product, guidance technology, and end-user.By product, the market includes biopsy tables, guidance systems, biopsy needles, biopsy wires, and others.By technique type, the market includes core needle biopsy, fine needle aspiration biopsy, wire localization, MRI-guided core needle biopsy, biopsy markers, surgical biopsy, and sentinel node biopsy.

The surgical biopsy segment is divided into excisional biopsy and incisional biopsy.By guidance technology, the market includes CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and various other image-guided breast biopsy (PET and thermography).By end-user, the market comprises of ambulatory surgical centers, hospitals, diagnostic centers, and others.Regional AnalysisThe geographical breast biopsy market segmentation covers four major regions, namely North America, Asia-Pacific, Europe, and the Middle East & Africa.North America is anticipated to hold the largest market share over the forecast period as per the market report published by MRFR.

The Europe market holds the second-largest share of the breast biopsy market due to the striking prevalence of breast cancer in the UK and Belgium.

Know more about breast cancer causes, symptoms, and treatment Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI, and biopsy.

Breast Cancer Treatment in Gurugram, Gurgaon, Haryana

Breast Biopsy Procedure in India.

It's a procedure in which the doctor takes a small sample of the breast tissue for testing.

There are several types of biopsy procedures to determine the specific area in the patient's breast.

The doctor examines and identifies the cells that are forming lumps, and other unusual changes.

Further, it determines if the patient needs treatment.

Contact us for more information.